hCG (standard) — Competitive Intelligence Brief

hCG (standard) (hCG (standard)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: gonadotropin. Area: Women's Health.

phase 3 gonadotropin hCG receptor Women's Health Small molecule

Target snapshot

hCG (standard) (hCG (standard)) — American University of Beirut Medical Center. hCG stimulates the production of progesterone from the corpus luteum, maintaining pregnancy.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
hCG (standard) TARGET	hCG (standard)	American University of Beirut Medical Center	phase 3	gonadotropin	hCG receptor
Ovulation triggering with GnRH-a+rhCG	Ovulation triggering with GnRH-a+rhCG	Fundación Santiago Dexeus Font	marketed	Gonadotropin-releasing hormone agonist combined with recombinant human chorionic gonadotropin	GnRH receptor (for GnRH-a component); LH/hCG receptor (for rhCG component)
Luveris®	Luveris®	Merck KGaA, Darmstadt, Germany	marketed	Gonadotropin; recombinant luteinizing hormone	Luteinizing hormone receptor (LHCG receptor)
Human chorionic gonadotrophin	Human chorionic gonadotrophin	The University of Hong Kong	marketed	Gonadotropin; Hormone replacement therapy	Luteinizing hormone receptor (LHCG receptor)
Low dose hCG plus FSH co-trigger	Low dose hCG plus FSH co-trigger	University of California, San Francisco	phase 3	Gonadotropin combination	FSH receptor and hCG receptor (LH/hCG receptor)
IVF: Decapeptyl and hCG	IVF: Decapeptyl and hCG	The University of Hong Kong	phase 3	GnRH agonist + gonadotropin	GnRH receptor (Decapeptyl); LH/hCG receptor (hCG)
Orgovyx	relugolix	MYOVANT SCIENCES	marketed	Gonadotropin Releasing Hormone Receptor Antagonist [EPC]	Gonadotropin-releasing hormone receptor	2020-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

• 2036-02-25 — Orgovyx · 10350170 · US
• 2037-09-29 — Orgovyx · 10449191 · US
• 2037-09-29 — Orgovyx · 11583526 · US
• 2037-09-29 — Orgovyx · 11033551 · US
• 2037-09-29 — Orgovyx · 10786501 · US

Sponsor landscape (gonadotropin class)

1. American University of Beirut Medical Center · 1 drug in this class
2. Dong-A Pharmaceutical Co., Ltd. · 1 drug in this class
3. IBSA Institut Biochimique SA · 1 drug in this class
4. University of California, San Francisco · 1 drug in this class